IMNM
Immunome Inc
24.00$
+0.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +13.8% | +779.9% | +30.1% | -58.5% | +517.7% | +61.7% | +184.4% | |
| – | +47.9% | +1,273.9% | +32.0% | -60.0% | +538.9% | +53.0% | +198.5% | |
| – | +58.7% | +1,463.7% | +23.8% | -58.7% | +385.6% | +45.3% | +355.9% | |
| – | +58.7% | +1,463.7% | +23.8% | -58.7% | +579.7% | +57.3% | +200.7% | |
| – | – | – | +407.3% | -80.4% | -65.9% | – | – | |
| – | – | – | – | – | – | – | – | |
| – | -18.3% | -9.9% | -44.2% | -20.4% | – | – | – | |
| – | +37.2% | -92.2% | +206.3% | -24.1% | +287.6% | +106.1% | -17.3% | |
| – | +6.7% | +82.5% | +220.2% | -24.6% | +197.8% | +148.8% | -17.2% | |
| – | -26.3% | +6.2% | -33.8% | -27.8% | +35.4% | -79.7% | – | |
| – | +15.9% | +116.6% | +159.2% | -22.0% | +38.0% | +328.5% | -76.5% | |
| – | -65.2% | +18.6% | – | – | – | – | – | |
| – | – | – | +16.5% | -65.4% | +619.9% | +51.1% | +250.1% | |
| – | – | – | – | – | – | – | – | |
| – | +425.8% | +76.0% | +14.1% | +5.1% | +63.6% | +195.5% | +49.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.